Style de citation APA (7e éd.)

X, L., Y, W., H, S., M, D., H, H., & Q, L. (2021). Nucleolin-Targeting AS1411 Aptamer-Modified Micelle for the Co-Delivery of Doxorubicin and miR-519c to Improve the Therapeutic Efficacy in Hepatocellular Carcinoma Treatment. Dove Medical Press.

Style de citation Chicago (17e éd.)

X, Liang, Wang Y, Shi H, Dong M, Han H, et Li Q. Nucleolin-Targeting AS1411 Aptamer-Modified Micelle for the Co-Delivery of Doxorubicin and MiR-519c to Improve the Therapeutic Efficacy in Hepatocellular Carcinoma Treatment. Dove Medical Press, 2021.

Style de citation MLA (8e éd.)

X, Liang, et al. Nucleolin-Targeting AS1411 Aptamer-Modified Micelle for the Co-Delivery of Doxorubicin and MiR-519c to Improve the Therapeutic Efficacy in Hepatocellular Carcinoma Treatment. Dove Medical Press, 2021.